MIFH
CRMD icon

Migdal Insurance & Financial Holdings’s CorMedix CRMD Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,174
Closed -$6K – 621
2021
Q4 		$6K Sell
1,174
-708
-38% -$3.52K ﹤0.01% 637
2021
Q3 		$9K Buy
+1,882
New +$11K ﹤0.01% 603

Other funds holding CRMD

Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Migdal Insurance & Financial Holdings's CRMD Position: Q1 2022 in Review

Migdal Insurance & Financial Holdings sold out of CorMedix (CRMD) in Q1 2022, closing a stake of 1,174 shares — an estimated $6K sold.

Migdal Insurance & Financial Holdings first reported a position in CRMD in Q3 2021 and held it in 2 quarters. The position peaked at $9K in Q3 2021. 85 funds tracked by Wall St. Rank hold CRMD as of Q1 2022.

  • Migdal Insurance & Financial Holdings reported no remaining CorMedix position as of Q1 2022 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 1,174 CorMedix shares in Q1 2022, an estimated $6K.
  • Migdal Insurance & Financial Holdings first reported a position in CorMedix in Q3 2021 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's CorMedix position peaked at $9K in Q3 2021.
  • 85 funds tracked by Wall St. Rank held CorMedix as of Q1 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2022, filed 2 May 2022.